ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,570 | -16.3% | 62,512 | +5.1% | 0.00% | -100.0% |
| Q2 2023 | $499,154 | +135.4% | 59,494 | +25.0% | 0.00% | – |
| Q1 2022 | $212,000 | +24.7% | 47,596 | +11.7% | 0.00% | – |
| Q4 2021 | $170,000 | -55.5% | 42,600 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $382,000 | -18.9% | 43,453 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $471,000 | +519.7% | 41,530 | +34.9% | 0.00% | – |
| Q1 2020 | $76,000 | -57.5% | 30,784 | 0.0% | 0.00% | – |
| Q4 2019 | $179,000 | +11.2% | 30,784 | +0.5% | 0.00% | – |
| Q3 2019 | $161,000 | -10.6% | 30,641 | +2.4% | 0.00% | – |
| Q2 2019 | $180,000 | -26.5% | 29,935 | +10.1% | 0.00% | – |
| Q1 2019 | $245,000 | +27.6% | 27,183 | +17.3% | 0.00% | – |
| Q4 2018 | $192,000 | 0.0% | 23,173 | +66.6% | 0.00% | – |
| Q3 2018 | $192,000 | +69.9% | 13,913 | -2.4% | 0.00% | – |
| Q2 2018 | $113,000 | – | 14,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |